Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TAKAHASHI, H.
Right arrow Articles by SHIRASU, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by TAKAHASHI, H.
Right arrow Articles by SHIRASU, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Contribution of Monoaminergic Nervous System in Potentiation of 2-sec-Butylphenyl N-Methylcarbamate (BPMC) Toxicity by Malathion in Male Mice1

HIROAKI TAKAHASHI, JUNKO TANAKA, SHUJI TSUDA and YASUHIKO SHIRASU

Mitsukaido Laboratories, Institute of Environmental Toxicology Uchimoriya-cho 4321, Mitsukaido-shi, Ibaraki 302-02, Japan

Contribution of Monoaminergic Nervous System in Potentiation of 2-sec-Butylphenyl N-Methylcarbamate (BPMC) Toxicity by Malathion in Male Mice. TAKAHASHI, H., TANAKA, J., TSUDA, S., and SHIRASU, Y. (1987). Fundam. Appl. Toxicol. 8, 415–422. Malathion-induced marked potentiation of BPMC toxicity (about fivefold) was analyzed by measuring LD50 as an index of acute toxicity. The acute lethality of BPMC was decreased by muscarinic blockers (atropine, methylatropine, or trihexyphenidyl) or a monoamine oxidase inhibitor (pargyline) and increased by a monoamine depleter (reserpine) or a dopaminergic blocker (haloperidol). The potentiation observed with BPMC and malathion was decreased by the muscarinic blockers, monoamine depleters (reserpine, {alpha}-methyl-p-tyrosine), an {alpha}-noradrenergic blocker (phen-tolamine), or haloperidol. The acute toxicities of other N-methylcarbamates MPMC (3,4-di-methylphenyl N-methylcarbamate), MTMC (3-methylphenyl N-methylcarbamate), NAC (1-naphthyl N-methylcarbamate), and XMC (3,5-dimethylphenyl N-methylcarbamate) were potentiated by malathion to a lesser degree than that of BPMC. Atropine protected against the lethalities of all N-methylcarbamates. Reserpine or haloperidol potentiated the lethalities of N-methylcarbamates with a similar tendency toward malathion. When the inhibitory effect of each N-methylcarbamate on brain acetylcholinesterase (AChE) was compared with its LD50, among five N-methylcarbamates BPMC had particularly strong anti-AChE activity. This characteristic of BPMC was not observed after the treatment with reserpine. These results suggest that BPMC may act not only on cholinergic nerves as an anti-AChE, but also on monoaminergic nerves which antagonize the lethal cholinergic effect. Malathion might inhibit the effect of BPMC on the monoaminergic nerves, thereby markedly potentiating the lethal effect of BPMC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.